Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$512.23
-0.8%
$537.54
$413.82
$616.00
$183.59B1.641.97 million shs1.65 million shs
Medtronic PLC stock logo
MDT
Medtronic
$89.26
-0.5%
$85.89
$76.68
$96.25
$114.47B0.87.04 million shs8.62 million shs
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
$58.01
-0.3%
$58.29
$47.04
$103.81
$3.21B1.07849,533 shs1.76 million shs
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
$93.99
+0.1%
$93.28
$89.22
$116.71
$18.60B0.711.83 million shs2.34 million shs
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
+0.86%-3.42%+0.83%+5.77%+16.27%
Medtronic PLC stock logo
MDT
Medtronic
-0.33%+2.27%+2.90%+9.07%+15.11%
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
+2.68%+2.11%-4.06%+9.92%-16.12%
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
-0.10%+1.31%+2.81%-3.53%-13.71%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
4.7095 of 5 stars
3.43.00.04.03.52.51.9
Medtronic PLC stock logo
MDT
Medtronic
4.8506 of 5 stars
3.33.03.34.12.91.71.9
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
2.2755 of 5 stars
3.41.00.00.02.52.50.6
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
4.9437 of 5 stars
3.25.02.53.72.62.52.5
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
2.70
Moderate Buy$592.8615.74% Upside
Medtronic PLC stock logo
MDT
Medtronic
2.59
Moderate Buy$98.069.87% Upside
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
2.78
Moderate Buy$84.1345.02% Upside
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
2.35
Hold$111.3918.51% Upside

Current Analyst Ratings Breakdown

Latest ISRG, PRCT, ZBH, and MDT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/15/2025
Medtronic PLC stock logo
MDT
Medtronic
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$98.00 ➝ $107.00
7/15/2025
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$71.00 ➝ $68.00
7/15/2025
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
Roth Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Buy$135.00
7/14/2025
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetBuy ➝ Buy$566.00
7/11/2025
Medtronic PLC stock logo
MDT
Medtronic
BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral
7/11/2025
Medtronic PLC stock logo
MDT
Medtronic
William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold
7/9/2025
Medtronic PLC stock logo
MDT
Medtronic
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$98.00 ➝ $99.00
7/9/2025
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOverweight$70.00
7/8/2025
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetIn-Line ➝ In-Line$470.00 ➝ $550.00
7/8/2025
Medtronic PLC stock logo
MDT
Medtronic
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$103.00 ➝ $106.00
7/8/2025
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetIn-Line ➝ In-Line$102.00 ➝ $96.00
(Data available from 7/15/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$8.35B21.98$7.99 per share64.10$46.41 per share11.04
Medtronic PLC stock logo
MDT
Medtronic
$33.54B3.41$7.69 per share11.60$37.62 per share2.37
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
$249.12M12.88N/AN/A$7.71 per share7.52
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
$7.68B2.42$13.22 per share7.11$62.67 per share1.50
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$2.32B$6.8275.1167.135.4328.41%14.43%12.81%7/22/2025 (Estimated)
Medtronic PLC stock logo
MDT
Medtronic
$4.66B$3.6224.6615.312.3313.90%14.54%7.83%8/19/2025 (Estimated)
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
-$91.41M-$1.70N/AN/AN/A-36.20%-28.09%-20.02%7/30/2025 (Estimated)
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
$903.70M$4.5220.7910.602.1711.86%12.73%7.34%8/6/2025 (Estimated)

Latest ISRG, PRCT, ZBH, and MDT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/7/2025Q2 2025
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
-$0.41N/AN/AN/AN/AN/A
8/6/2025Q2 2025
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
$1.99N/AN/AN/A$2.06 billionN/A
7/22/2025Q2 2025
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$1.92N/AN/AN/A$2.35 billionN/A
5/21/2025Q4 2025
Medtronic PLC stock logo
MDT
Medtronic
$1.58$1.62+$0.04$0.82$8.81 billion$8.93 billion
5/5/2025Q1 2025
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
$1.77$1.81+$0.04$0.91$1.89 billion$1.91 billion
4/24/2025Q1 2025
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
-$0.49-$0.45+$0.04-$0.45$65.39 million$69.16 million
4/22/2025Q1 2025
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$1.71$1.81+$0.10$1.92$2.19 billion$2.25 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
N/AN/AN/AN/AN/A
Medtronic PLC stock logo
MDT
Medtronic
$2.843.18%N/A78.45%49 Years
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
N/AN/AN/AN/AN/A
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
$0.961.02%N/A21.24%N/A

Latest ISRG, PRCT, ZBH, and MDT Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/30/2025
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
quarterly$0.241.03%6/26/20256/26/20257/31/2025
5/21/2025
Medtronic PLC stock logo
MDT
Medtronic
quarterly$0.713.3%6/27/20256/27/20257/11/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
N/A
4.98
3.97
Medtronic PLC stock logo
MDT
Medtronic
0.53
1.85
1.42
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
0.13
8.95
7.75
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
0.53
2.44
1.46

Institutional Ownership

CompanyInstitutional Ownership
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
83.64%
Medtronic PLC stock logo
MDT
Medtronic
82.06%
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
89.46%
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
88.89%

Insider Ownership

CompanyInsider Ownership
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
0.70%
Medtronic PLC stock logo
MDT
Medtronic
0.20%
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
6.60%
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
0.70%
CompanyEmployeesShares OutstandingFree FloatOptionable
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
15,638358.42 million355.91 millionOptionable
Medtronic PLC stock logo
MDT
Medtronic
95,0001.28 billion1.28 billionOptionable
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
43055.33 million45.70 millionOptionable
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
17,000197.85 million196.46 millionOptionable

Recent News About These Companies

Zimmer Biomet (NYSE:ZBH) Raised to Buy at Roth Capital
Zimmer Biomet to acquire Monogram Technologies for $177M
Citi Remains a Hold on Zimmer Biomet Holdings (ZBH)
Zimmer Biomet, Getinge ink ASC partnership

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Intuitive Surgical stock logo

Intuitive Surgical NASDAQ:ISRG

$512.23 -4.21 (-0.82%)
Closing price 04:00 PM Eastern
Extended Trading
$509.32 -2.91 (-0.57%)
As of 04:45 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.

Medtronic stock logo

Medtronic NYSE:MDT

$89.26 -0.48 (-0.53%)
Closing price 03:59 PM Eastern
Extended Trading
$89.20 -0.05 (-0.06%)
As of 04:35 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.

PROCEPT BioRobotics stock logo

PROCEPT BioRobotics NASDAQ:PRCT

$58.01 -0.16 (-0.28%)
Closing price 04:00 PM Eastern
Extended Trading
$58.02 +0.01 (+0.02%)
As of 04:33 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.

Zimmer Biomet stock logo

Zimmer Biomet NYSE:ZBH

$93.99 +0.13 (+0.14%)
Closing price 03:59 PM Eastern
Extended Trading
$93.95 -0.04 (-0.04%)
As of 04:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers robotic, surgical, and bone cement products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.